Potential for Recovery of Voluntary Finger Extension After Stroke (PROVES)
Stroke patients with absent voluntary finger extension (VFE) 6-months after stroke are not expected to recover hand function. However, experience from the Queen Square Upper Limb neurorehabilitation service contradicts this view. In this study, we will identify the characteristics of those chronic stroke patients who regain previously absent VFE.
Hundred chronic stroke patients will be recruited with absent/negligible VFE in an external pilot and feasibility study. Transcranial magnetic stimulation will be used to determine the functional integrity of descending white matter pathways. Corticospinal tract integrity to finger extensor muscles will be based on whether motor-evoked potentials are present (MEP+) or absent (MEP-). Reticulospinal tract activity will be assessed by measuring ipsilateral MEP amplitudes and the Start-React response.
All patients will then receive 3-months of neuromuscular electrical stimulation plus home exercise, designed to strengthen wrist/finger extensors, reduce spasticity and increase corticospinal excitability. The primary outcome measure will be restoration of VFE.
It is predicted that VFE will be restored in MEP+ but not MEP- patients. MEP- patients will have higher reticulospinal tract activity associated with spasticity. Restoration of VFE will allow patients to engage in evidence-based upper limb training to improve function e.g. constraint induced movement therapy or repetitive task training.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Professor Nick Ward, MD
- Numéro de téléphone: +44 20 3448 3486
- E-mail: n.ward@ucl.ac.uk
Sauvegarde des contacts de l'étude
- Nom: Lisa Tedesco Triccas, PhD
- E-mail: l.triccas@ucl.ac.uk
Lieux d'étude
-
-
-
London, Royaume-Uni, WC1N 3BJ
- University College London- Department of Clinical and Movement Neurosciences
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria
- Diagnosed with a Stroke >6 months previously
- Medical Research Council (MRC) grade 0 or 1 in long finger extensors.
Exclusion Criteria
- Presence of spasticity in any wrist/finger flexors (including lumbricals) >2 on Modified Ashworth Scale
- Unable to get hand flat on table top
- Botulinum toxin to long finger or wrist flexors < 24 weeks prior to pre-treatment assessment (i.e. effects should have worn off).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Diagnostique
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Neuromuscular electrical stimulation (NMES) and home exercise programme
Three month intervention programme of Neuromuscular electrical stimulation (NMES) and home exercise programme
|
-Neuromuscular and Electrical Stimulation (NMES): All participants will undergo a NMES treatment programme designed to strengthen wrist and finger extensors. Participants and their carers will receive training in NMES set up from the research physiotherapist. Surface electrodes are placed over the motor points of extensor carpi radialis and extensor digitorum communis to produce wrist and finger extension simultaneously. Home exercise: We aim for all patients to perform the Graded Repetitive Arm Supplementary Program (GRASP) level 1 (for severely affected upper limbs) for a minimum of 60 minutes/day, 5 days/week. Patients will be provided with an exercise book containing written and pictorial instructions for each exercise, and the kits contained inexpensive equipment to complete the exercises. Exercises included strengthening of the arm and hand, range of motion, and gross and fine motor skills. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Voluntary Finger Extension (VFE)
Délai: Day 1 and Day 90
|
Can participants achieve at least 10° of thumb abduction/extension, and at least 10° of extension in a minimum of 2 additional digits (movements need to be repeatable 3 times in 1 minute).
The extent of VFE will be measured using an electronic goniometer.
Extent of finger extension is calculated for each finger as a composite of extension at metacarpophalangeal, proximal and distal interphalangeal joints.
|
Day 1 and Day 90
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Upper Extremity Fugl-Meyer Assessment
Délai: Day 1 and Day 90
|
Measurement of upper limb motor recovery after stroke
|
Day 1 and Day 90
|
|
Hand Dynamometry
Délai: Day 1 and Day 90
|
Measurement of grip strength
|
Day 1 and Day 90
|
|
Fugl-Meyer Assessment - Sensory function
Délai: Day 1 and Day 90
|
As of part of the Fugl-Meyer Assessment, this measure is used to evaluate somatosensory function of the upper limbs.
|
Day 1 and Day 90
|
|
Modified Tardieu Scale (MTS)
Délai: Day 1 and Day 90
|
MTS is a clinical tool used to assess spasticity.
|
Day 1 and Day 90
|
|
KINARM- Passive Stretch Task
Délai: Day 1 and Day 90
|
The KINARM Passive Stretch Task is a quantitative assessment performed with the KINARM robotic assessment system in which the participant's limb is passively displaced by the robot while they are instructed to remain relaxed.
The device applies controlled position- or torque-driven perturbations to one or more joints (typically elbow and/or shoulder) across predefined velocities and ranges of motion.
|
Day 1 and Day 90
|
|
Box and Block Test (BBT)
Délai: Day 1 and Day 90
|
BBT is a standard assessment to measure manual dexterity and gross motor coordination of the hands.
|
Day 1 and Day 90
|
|
Stroke Impact Scale (SIS)
Délai: Day 1 and Day 90
|
SIS is a self-reported questionnaire designed to measure the multidimensional impact of stroke on a person's life.
|
Day 1 and Day 90
|
|
Neurophysiological- Corticospinal Tract Integrity
Délai: Day 1 and Day 90
|
Corticospinal tract integrity is measured using Transcranial Magnetic Stimulation (TMS) to evaluate the functional status of motor pathways in the brain and spinal cord - identified as Motor Evoked Potential Positive (MEP+) or Negative (MEP-).
Resting and Active Motor Threshold will also be measured in addition with the Compound Muscle Action Potential.
|
Day 1 and Day 90
|
|
Neurophysiological- Reticulospinal Tract Integrity
Délai: Day 1 and Day 90
|
This will be assessed using the Start React Protocol and measurement of ipsilateral Motor Evoked Potentials (iMEPs).
|
Day 1 and Day 90
|
|
Neurophysiological- Somatosensory Evoked Potentials
Délai: Day 1 and Day 90
|
Median nerve somatosensory evoked potentials will be measured using Electroencephalography (EEG).
The measures will mainly involve recording cortical responses to peripheral nerve stimulation.
|
Day 1 and Day 90
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Nick Ward, MD, University College, London
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 367119
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .